Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A metabolomic approach to elucidate the inhibitory effects of baicalin in pulmonary fibrosis
Hong Chang, Hongyu Meng, Wanfu Bai, et al.
Pharmaceutical Biology (2021) Vol. 59, Iss. 1, pp. 1014-1023
Open Access | Times Cited: 21

Showing 21 citing articles:

Efficacy evaluation, active ingredients, and multitarget exploration of herbal medicine
Junling Ren, Le Yang, Shi Qiu, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 3, pp. 146-157
Closed Access | Times Cited: 54
Pharmacological effects of baicalin in lung diseases
Duoning Wang, Yi Li
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 31
Monomeric compounds from traditional Chinese medicine: New hopes for drug discovery in pulmonary fibrosis
Qi Wang, Wenjun Li, Haibo Hu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114226-114226
Open Access | Times Cited: 28
Research progress of traditional Chinese medicine compound "Xiaochaihu Decoction" in the treatment of depression
Chunyan Sun, Mingzhou Gao, Mingqi Qiao
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114249-114249
Open Access | Times Cited: 18
Flavonoids for treating pulmonary fibrosis: Present status and future prospects
Anju Sharma, Sarika Wairkar
Phytotherapy Research (2024) Vol. 38, Iss. 9, pp. 4406-4423
Closed Access | Times Cited: 7
The protective effects of baicalin for respiratory diseases: an update and future perspectives
Siyu Song, Lu Ding, Guangwen Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Baicalin and lung diseases
Zeina W. Sharawi, Islam M. Ibrahim, Esraa K. Abd‐alhameed, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 3, pp. 1405-1419
Closed Access | Times Cited: 12
Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms
Yanwei Hao, Jiaxin Li, Lijuan Dan, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116836-116836
Closed Access | Times Cited: 11
Integrating Metabolomics and Network Analyses to Explore Mechanisms of Geum japonicum var. chinense Against Pulmonary Fibrosis: Involvement of Arachidonic Acid Metabolic Pathway
Junyan Ran, Qian Wang, Tao Lu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1462-1462
Open Access
Advances in pharmacology, biosynthesis, and metabolic engineering ofScutellaria-specialized metabolites
Xinyi Yang, Sihao Zheng, Xiaotong Wang, et al.
Critical Reviews in Biotechnology (2022) Vol. 44, Iss. 2, pp. 302-318
Open Access | Times Cited: 14
A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective
Shanbo Qin, Peng Tan, Junjie Xie, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Longitudinal assessment of bleomycin-induced pulmonary fibrosis by evaluating TGF-β1/Smad2, Nrf2 signaling and metabolomic analysis in mice
Kaveri R. Washimkar, Manendra Singh Tomar, Chirag Kulkarni, et al.
Life Sciences (2023) Vol. 331, pp. 122064-122064
Closed Access | Times Cited: 7
Baicalin inhibits oxidative injures of mouse uterine tissue induced by acute heat stress through activating the Keap1/Nrf2 signaling pathway
Huatao Li, Cong Xia, Wenhui Yu, et al.
Research in Veterinary Science (2022) Vol. 152, pp. 717-725
Closed Access | Times Cited: 10
The mechanism of Qingwen Gupi decoction on pulmonary fibrosis based on metabolomics and intestinal flora
Chen Gao, Hong Chang, Zixuan Wang, et al.
Journal of Applied Microbiology (2022) Vol. 134, Iss. 1
Open Access | Times Cited: 10
Protective role of baicalin in the dynamic progression of lung injury to idiopathic pulmonary fibrosis: A meta-analysis
Jiajie Jiang, Te-chan Kao, Sihan Hu, et al.
Phytomedicine (2023) Vol. 114, pp. 154777-154777
Closed Access | Times Cited: 5
Baicalin Inhibits Inflammation in Rats with Chronic Obstructive Pulmonary Disease by the TLR2/MYD88/NF-κBp65 Signaling Pathway
Jiangang Ju, Zheming Li, Qiang Shi
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 8
Multi‐omics integration reveals a nonlinear signature that precedes progression of lung fibrosis
Céline Pattaroni, Christina Begka, Bailey Cardwell, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Global research status and trends of interactions between Traditional Chinese medicine and pulmonary fibrosis: A new dawn in treatment
Bokai Wei, Hao‐Zheng Li, Chengyu Wang, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34592-e34592
Open Access | Times Cited: 1
Recent Advances in Traditional Chinese Medicine for Treatment of Podocyte Injury
Tianwen Yao, Wenxiang Su, Shisheng Han, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Metagenomics combined with untargeted metabolomics to study the mechanism of miRNA-150-5p on SiO2 -induced acute lung injury
Xiaodong Wu, Qin Ling, Miao Song, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 252, pp. 116515-116515
Closed Access
Peimine Alleviated Bleomycin-Induced Pulmonary Fibrosis in Mice Through Reducing Epithelial-Mesenchymal Transition, Inflammation and Oxidative Stress and Regulating Host Metabolism
Xiaojuan Li, Feng Zhang, Aijuan Shen, et al.
Natural Product Communications (2023) Vol. 18, Iss. 11
Open Access
Page 1

Scroll to top